MannKind Corporation (MNKD)
NASDAQ: MNKD · Real-Time Price · USD
5.35
-0.14 (-2.55%)
Oct 24, 2025, 3:02 PM EDT - Market open
MannKind Revenue
MannKind had revenue of $76.53M in the quarter ending June 30, 2025, with 5.72% growth. This brings the company's revenue in the last twelve months to $301.74M, up 21.48% year-over-year. In the year 2024, MannKind had annual revenue of $285.50M with 43.50% growth.
Revenue (ttm)
$301.74M
Revenue Growth
+21.48%
P/S Ratio
5.29
Revenue / Employee
$741,366
Employees
407
Market Cap
1.64B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 285.50M | 86.54M | 43.50% |
| Dec 31, 2023 | 198.96M | 99.19M | 99.42% |
| Dec 31, 2022 | 99.77M | 24.33M | 32.25% |
| Dec 31, 2021 | 75.44M | 10.30M | 15.81% |
| Dec 31, 2020 | 65.14M | 2.11M | 3.34% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
MNKD News
- 9 days ago - MannKind: Durable Cash Engine, Optional Catalysts Pending - Seeking Alpha
- 11 days ago - MannKind Announces U.S. FDA Accepts for Review its Supplemental Biologics License Application (sBLA) for Inhaled Insulin (Afrezza) in Children and Adolescents Aged 4-17 Years Living with Diabetes - GlobeNewsWire
- 17 days ago - MannKind Completes Acquisition of scPharmaceuticals, Accelerating Revenue Growth in Cardiometabolic Care - GlobeNewsWire
- 25 days ago - MannKind Appoints Dr. Ajay Ahuja as Executive Vice President and Chief Medical Officer - GlobeNewsWire
- 5 weeks ago - SCPHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of scPharmaceuticals Inc. - SCPH - Business Wire
- 6 weeks ago - MannKind Corporation (MNKD) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript - Seeking Alpha
- 6 weeks ago - MannKind Corporation (MNKD) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 Transcript - Seeking Alpha
- 6 weeks ago - MannKind Corporation (MNKD) Presents At Cantor Global Healthcare Conference 2025 Transcript - Seeking Alpha